• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Another lawsuit for Olympus over ‘superbug’-infected scopes

Another lawsuit for Olympus over ‘superbug’-infected scopes

March 18, 2015 By MassDevice Contributors Network

Another lawsuit for Olympus over 'superbug'-infected scopes

(Reuters) — A 76-year-old man infected with a drug-resistant “superbug” at a Los Angeles hospital has sued the manufacturer of a medical device that allegedly caused the illness in the 5th lawsuit related to the bacterial outbreak at the facility, his attorney said yesterday.

Plaintiff Domingo Gomez, who was infected by a contaminated device during an endoscopy at UCLA Ronald Reagan Medical Center, suffered significant harm from the infection, according to his lawsuit filed in Los Angeles Superior Court.

Gomez’ attorney, Peter Kaufman, declined in a phone interview to release more information about the man’s condition or say why he initially went to the large teaching hospital.

UCLA Ronald Reagan Medical Center officials have acknowledged that 7 people were infected with carbapenem-resistant enterobacteria, or CRE, during endoscopies at the hospital between Oct. 3, 2014, and Jan. 28 and that 2 of them later died.

Kaufman said his firm has filed lawsuits against  Olympus (TYO:7733), the manufacturer of the endoscope device, in 5 of those cases, including on behalf of Gomez. He said he was unaware of any other suits tied to the outbreak at UCLA Ronald Reagan Medical Center.

The complex design of the endoscopes, which are used to examine a patient’s digestive tract, linked to the California outbreak may hinder proper cleaning, the FDA has warned.

Hospital officials have said that, aside from the 7 cases of confirmed infections, 172 former patients were informed they may have been exposed to the superbug and they were offered home test kits.

No new infections have been discovered among that group, but 4 former patients were determined to be carriers of the disease, which does not put them at immediate risk, said Dale Tate, a spokeswoman for UCLA Ronald Reagan Medical Center.

A spokesman for Olympus declined to comment on the lawsuit.

Earlier this month, the widow of a patient who died after being infected with E. coli by an Olympus endoscope sued Seattle’s Virginia Mason Medical Center and the company for wrongful death. And a top Los Angeles hospital, Cedars-Sinai Medical Center, said in March that 4 patients had been infected with bacteria from a contaminated scope and 67 more were at risk. Across the country in Connecticut, Hartford Hospital has also reported a similar outbreak involving at least 5 infections and more than 280 potential exposures.

Between 2013 and 2014, the FDA said it received reports of 135 possible microbial transmission from reprocessed duodenoscopes. The federal safety watchdog has been under pressure to review current protocol of sterilizing the instruments after a string of superbug outbreaks at hospitals across the country.

Although the FDA has said Olympus put its TJF-Q180V duodenoscope on the market without the agency’s clearance, Olympus claims that, based on the FDA’s policy, a modified version of its previously approved scope did not require a new marketing approval.

Top makers of the devices include Olympus, Fujifilm Holdings (TSE:4901) and Hoya Corp.‘s (TYO:7741) Pentax subsidiary.

Filed Under: Endoscopic, Hospital Care, Legal News, News Well Tagged With: Olympus

More recent news

  • GI Windows wins FDA nod for magnet tech
  • China reportedly launches country’s first invasive BCI trial
  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy